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Abstract 
The purpose of this research was to synthesize polymer based smart 
nanosystems for delivery of important bioactive natural products such as 
sesquiterpene coumarin derivatives of ferula szowitsiana, farnesiferol C as a 
potent anticancer. To this aim, polymeric micelles were prepared using N-
isopropylacrylamide (NIPAAM), vinyl pyrrolidone (VP) and methacrylate 
(MAA) as monomers which were cross-linked with N, N-methylene bis-
acrylamide (MBA). The molar ratio of the PNIPAAm: VP: MAA group was 
75.7:9.5:14.8. These micelles were further characterized upon their 
physicochemical properties using particle size analyzer, FT-IR, H-/C-NMR, 
HPLC. Particle size analyzer resulted in ~500 nm micelles with ~95% drug 
entrapments. Drug release from the polymeric micelles after 300 hours at 
37°C and 40°C were 60 and 98 %, respectively. Upon these findings, it is 
proposed that the P (N-isopropylacrylamide-co-Methacrylic acid-co-
Vinylpyrrolidone) micelles may be considered as thermosensitive delivery 
nanosystem.   
 
Keywords: N-isopropylacrylamide; Thermosensitive; Nanoparticles; 
Farnesiferol C; Amphiphilic polymers. 
 
 
Introduction  
Herbal medicine has been regarded as primitive 
medicaments paradigms for many years. These kinds 
of remedies are believed to possess great curing 
potentials for a wide range of diseases as they appear 
to be safer medicines possessing an inveterate 
precedence [1, 2]. It seems that the emergence of the 
phytomedicines with smart delivery systems (e.g., 
synthetic/biodegradable polymer based nanosystems) 
may advance development of more efficient herbal 
medicines. So far, many natural products have been 
reported with different therapeutic effects.  
 
Of these, based upon our preliminary findings, the 
species of Ferula (subfamily of Umbelliferae) grown 
in the Mediterranean area such as northwest of Iran 
[3] produces secondary metabolites with anti-cancer 
activities. Likewise, some recently published works 
have reported this genus as a good source of 
biologically active compounds such as sesquiterpene 
and coumarin derivatives (e.g., Farnesiferol C) [3]. 
Interestingly, the isolated compounds from this genus 
were shown to possess different therapeutic effects in 
cancers and leishmaniosis [3, 4].  
 doi:10.5138/ijdd.2010.0975.0215.02039 
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Further, polymeric micelles structured from 
amphiphilic copolymers are regarded as one of the 
most promising carriers for drug delivery [5, 6, 7]. 
The self-assembled structures are composed of two 
basic compartments of hydrophobic core and 
hydrophilic corona, at which they have been used to 
solubilize poorly soluble drugs/compounds [8, 9, 10]. 
Owing to such supramolecular structure, the 
hydrophobic drugs can associate with the inner cores 
of polymers, while the hydrophilic shells of polymer 
interact with the external environment. These 
polymeric self-assembled have been considered as 
one of the promising drug carriers which confer 
higher drug concentrations in an aqueous milieu 
where the solubility is deemed to limit the 
partitioning of hydrophobic drugs [11, 12, 13, 14, 15, 
16]. Poly (N-isopropylacrylamide) (PNIPAAm) and 
related copolymers have been widely investigated as 
stimuli sensitive polymers [17, 18]. PNIPAAm 
polymers display unique reversible thermosensitivity 
with the hydrated extended coil to globule transition 
by increasing temperature over its lower critical 
solution temperature [17, 18, 19, 20].  
In this study, we report the synthesis and 
characterization of the PNIPAAm nanostructured 
polymers, which were used as a smart 
thermosensitive nanocarrier for delivery of 
farnesiferol C.  
 
Materials and methods 
Chemicals preparations  
NIPAAm (Fluka, Deisenhofen, Germany) was 
purified by recrystallization in hexane and dried under 
vacuum at 25°C. VP (Merck, Hohenbrunn, Germany) 
was freed from stabilizer by twice vacuum distillation 
with continuous bubbling argon. Methacrylic acid 
(MAA) (Fluka, Deisenhofen, Germany) was used as 
supplied. Initiator ammonium persulfate (APS) 
(Sigma-Aldrich Co., Steinheim, Germany) was 
purified by recrystallization in EtOH:H2O (2:1) 
solvent mixture and dried under vacuum at 40°C and 
N, N%-Methylene bis-acrylamide (MBA) (Sigma-
Aldrich Co., Steinheim, Germany) was used directly 
without further purification. Sodium monohydrogen 
phosphate and dihydrogen phosphate was purchased 
from Sigma-Aldrich Co. (Steinheim, Germany). 
Silica gel (60F 254) and acetone were product of 
Merck (Darmstadt, Germany). 
Preparation of Extract and Chromatography 
The roots of F. szovitsiana were collected from Khoy 
(West Azerbaijan province, north-west of Iran). They 
were air-dried at room temperature and powdered. 
The chloroform extract was prepared by macerating 
the powder for 48 h with three changes of solution at 
room temperature. The combined solvent extracts 
were evaporated to yield a brownish, viscous residue 
(8% yields). The residue was fractionated by thin 
layer chromatography (TLC) on silica gel using 
petroleum ether: ethyl acetate (2:1) as the solvent 
system. The fractions were visualized under UV light 
at 254 nm and then eluted using acetone. Active 
constituent was abundantly purified as follow: briefly, 
15 g the extract was subjected to column 
chromatography on silica gel (5_50 cm) using 
petroleum ether with increasing volumes of acetone 
[petroleum ether(100), petroleum ether–acetone (95 : 
5), (90 : 10), (85 : 15), (80 : 20), (75 : 25), (70 : 30), 
(60 : 40), (50 : 50) and acetone (100) ]. The fractions 
were compared by TLC (silica gel using petroleum 
ether–EtOAc as solvent), and those giving similar 
coumarin spots were combined and further purified 
on preparative TLC to give Farnesiferol C (5.43 mg). 
The melting point, H- and C-NMR data of the 
obtained isolated farnesifeol C were confirmed 
according to previously published works [21, 22, 23].  
 
Synthesis of Farnesiferol C loaded nanopolymers 
A copolymer of NIPAAM-VP-MAA was synthesized 
through free radical mechanism. Water soluble 
monomers, NIPAAM, VP and MAA, were used in 
75.7:9.5:14.8 molar ratios and the polymer were 
cross-linked with MBA. Using a standard 
experimental protocol, 900 mg NIPAAM, 98 mg VP 
and 38 ml MAA (also freshly distilled) were mixed in 
50 ml of water. To cross-link the polymer chain, 300 
ml of MBA (0.049 g/ml) was added in the aqueous 
solution of monomers. Predetermined amount of 
Farnesiferol-C was included to reaction solution. The 
dissolved oxygen was removed by passing nitrogen 
gas for 30 min. To initiate the polymerization, APS 
(0.3 mol% with respect to the monomers) was added 
to mixture. The polymerization was fulfilled at 30°C 
for 24 h in nitrogen atmosphere. The mixture was 
purified by dialysis for 5 days using dialysis 
membrane (Cellu SepH1) with MWCO of 2000 and 
the external aqueous solution was removed two times 
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a day and displaced with fresh distilled water. The 
dialyzed aqueous solution of polymeric micelles was 
ultracentrifugation (8000 rev.min-1) immediately to 
obtain dry powder for subsequent use. The yield of 
micelle nanoparticles was above 80%.  
 
Determination of drug content of the nanoparticles 
To determine drug entrapment within the 
nanoparticles, 100 mg dried powder of nanoparticles 
was dissolved in 100 mL water. After complete 
dissolution of the polymer, the designated amount of 
drug was quantified using a high performance liquid 
chromatography (HPLC) method. The HPLC system 
consisted of a Waters 515 pump, automatic injector 
(7plus Waters autosampler), and Waters 2487 dual k 
absorbance detector. Chromatographic separation was 
achieved with a Nucleosil (Phenomenex) ODS 5 lm 
(25 cm 3 4.6 mm, i.d.) column and HPLC grade 
water, acetonitrile (15/85) with 0.1% trifluoroacetic 
acid (TFA) as the mobile phase at a flow rate of 
HPLC flow rate 1 mL.min-1 (in a stepwise increasing 
up to 2 mL.min-1) and the pressure was adjusted up to 
1100 psi. The UV detection was at 320 nm. The run 
time for the assay was 15 min and the retention time 
for Farnesiferol-C was 7.349 min. Farnesiferol-C 
loading efficiencies of nanoparticles were measured 
using following equation [18, 11]: 
Loading efficiency = (A/B) ×100  
Where, A and B are the amount of remained drug in 
the polymer and initial feeding amounts of drug, 
respectively.  
 
Drug release studies 
The in vitro release of Farnesiferol C from 
nanoparticles was carried out at 37 and 40°C.  
Farnesiferol C suspension (2mL containing 
nanoparticles 100 mg) was taken into a dialysis 
membrane (cut off: 2000; Sigma-Aldrich Co., 
Steinheim, Germany). It was allowed to float in a 
beaker containing 20 mL of phosphate buffered saline 
(PBS; pH 7.4). The beakers were placed in a shaker 
incubator maintained at 37°C and 40°C in 100 
rev/min. Aliquots of 2 mL were removed from the 
external buffer solution on designated time point up 
to 300 hours and the lost volume was replenished 
with fresh PBS. The released Farnesiferol C was 
analyzed using a HPLC assay as described 
previously. The results were presented in the terms of 
cumulative release as a function of time: 
( ) 100% releasedamount  Cumulative
0
×⎟⎠
⎞⎜⎝
⎛= ∑=
=
tt
t
ot MM  
Where, ∑=
=
tt
0t
0t MM  is the cumulative amount of 
released Farnesiferol C from the nanoparticles at time 
t, and M0 is the total amount of Farnesiferol C  in the 
nanoparticles [24, 18, 17]. 
 
Physicochemical characterization of polymeric 
micelles and Farnesiferol C 
FT- IR spectra of polymer and Farnesiferol C were 
taken in KBr pellet using Shimadzu Fourier 
Transformed Infrared (FT-IR) spectrophotometer 
instrument (Shimadzu FT-IR 8400 S, Kyoto, Japan).  
The chemical composition of the synthesized 
Farnesiferol C was determined by 1H NMR and 13C-
NMR (Bruker spectra spin 400 MHz, Leipzig, 
Germany). 
The average size of the polymeric nanoparticles was 
observed by using a laser diffraction particle size 
analyzer (Shimadzu SALD 2101, Kyoto, Japan). 
 
Results and discussion 
Synthesis and characterization of NIPAAM-VP-
MAA copolymeric micelles 
Random copolymerization of NIPAAM with VP and 
MAA, i.e. poly (NIPAAM-VP-MAA), was 
accomplished by radical polymerization process of 
the micellar aggregates of the monomers. These 
polymers possess amphiphilic characteristic, 
presumably with a hydrophobic core inside the 
micelles and hydrophilic outer shell composed of 
hydrated amides, pyrrolidone and carboxylic groups 
projected from the monomeric units. Water insoluble 
drug like Farnesiferol C was dissolved into the 
hydrophobic core of the polymeric micelles. Figure 1 
shows the FT-IR spectra of poly (NIPAAM-VP-
MAA), where an intense peak at 3345 cm-1   can be 
attributed to the COOH group of MAA. The C-H 
stretching vibration of the polymer backbone is 
manifested through strong peak at 2928 cm-1. 
Absorbance of amide carbonyl groups in PNIPAAm 
occurs at 1650 cm-1, bending frequency of amide N–
H appears at 1550 cm-1.  
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Figure 1. The FT-IR spectrum of NIPAAM-VP-MAA copolymeric micelles. 
 
 
Characterization of Farnesiferol C: 1H-NMR, 13C-
NMR of Farnesiferol C 
Figure 2 represents the molecular structure of 
Farnesiferol C. This coumarin based compound 
displays substantial structural commonalities in 1H-
NMR (Figure 3) and 13C-NMR (Figure 4) spectrums.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Structure of Farnesiferol C. 
 
As shown in Figure 3, the most important 
characteristic of 1H-NMR is the presence of two 
doublet peaks at 6.2 and 7.6 ppm that related to 3, 4 
protons and two doublet peaks at 6.8 and 7.3 ppm 
related to 5, 6 protons in coumarin ring, respectively. 
One doublet peak at 3.72 ppm related to 8' proton, 
one doublet peak at 4.6 ppm related to 1', one triplet 
peak at 5.45 ppm related to 2', two singlet peaks at 
1.33 and 1.76 ppm related to 12' and 13' protons 
respectively and two singlet peaks at 1.02 and 1.03 
ppm related to 14' and 15' protons respectively (Table 
1). As shown in Figure 4, the 13C-NMR spectrum 
reveals two short peaks at 161 and 162 ppm 
respectively related to 7 and 2 carbons. Also, a peak 
at 65-70 ppm is related to 11' carbon. This distinct 
peak displays a constant characteristic of the 
coumarin structure. These data are in consensus with 
the results reported previously [21, 3].  
 
In vitro drug release 
One of the main goal in this research is investigation 
of stimuli responsive, especially temperature sensitive 
polymeric nanoparticles an efficient drug carrier. To 
investigate the effect of environmental temperatures 
on drug release behaviors, In vitro Farnesiferol C 
release from the micelles was studied in PBS at 37 °C 
and 40°C. As illustrated in Figures 5, the Farnesiferol 
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C loaded nanoparticles showed well-developed 
sustained drug release patterns which was in 
correlation with temperature. Polymeric micelles 
yielded the initial burst release of Farnesiferol C, 
reaching 24 and 50 % in first two days at 37 °C and 
40°C, respectively. The initial burst release of 
Farnesiferol C from nanoparticles is much faster at 
higher temperatures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  The 1H-NMR spectrum of Farnesiferol C. 
 
When the temperature increased, the outer shell 
collapsed. After 300 hours incubation at 37°C and 
40°C, the drug release from micelles was respectively 
60% and 98%. Such low release is attributed with the 
insolubility of the drug in aqueous solution as well as 
the low diffusion coefficient of Farnesiferol C in the 
micelle core. The collapsed shell might induce the 
deformation of the core–shell structure, exposing 
Farnesiferol C molecules to the external in vitro 
release medium and thus accelerating drug release. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 4.  The 13C-NMR spectrum of Farnesiferol. 
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Solubilities and other physicochemical properties of 
nanoparticles are essential requirements for drug 
advancement from pharmaceutical technology 
towards clinical trials and applications [25, 26, 27]. 
Given the integration of nanomaterials with herbal 
medicine for providing more efficient medications, 
we focused on exploitation of bioactive derivatives 
from plant resources that provide huge potential for 
novel biologically active compounds such as anti-
inflammatory, anticancer, antiviral, antibacterial, and 
antioxidant agents. Ferula genus from Umbelliferae 
family, which is naturally distributed throughout the 
Mediterranean to Central Asia [21, 22, 3], seems to 
confer interesting bioactivities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. In vitro Farnesiferol C release from 
NIPAAM-VP-MAA copolymeric micelles as a 
function of time at pH 7.4 in 37 ºC and 40 ºC. 
 
In our preliminary investigation, we have found some 
non-polar fractions from a chloroform extract of 
ferula szowitsiana roots, which were examined for its 
anticancer activities using several human cancer cell 
lines by means of the routinely used MTT assay (our 
unpublished data). Similarly, Dehghan et al., (2007), 
recruiting acridine orange/Ethidium bromide double 
staining methodology, reported the induction of 
caspase–3 activities leading to apoptosis in the ht-29 
cells treated with Farnesiferol C. intriguingly, the 
morphological studies showed chromatin 
condensation and detaching of adherent cells treated 
with chloroform extract and fractions of Farnesiferol 
C, resulting in profound inhibition of the cell 
proliferation in human cancer cell lines perhaps 
through induction of apoptosis [28, 21, 22, 4]. The 
relatively high cytotoxic potential Farnesiferol C 
directed us to formulate it as a nano-scaled product 
using biodegradable polymers to maximize its 
biological impact. In fact, it is now well documented 
that exploitation of appropriate nanomaterials can 
improve the effectiveness of treatment, perhaps 
though more efficient targeting potential of these 
nano-structured medicines in cancer cells while 
imposing minimal adverse consequences [25]. Of 
these, the amphiphilic block copolymers have been 
intensively used as nano-/micro-micelles for drug 
delivery and targeting purposes. In fact, the 
selfaggregates formed by polymeric amphiphiles are 
composed of hydrophobic core and hydrophilic 
corona. Owing to such supramolecular structure, they 
have been considered as a promising drug delivery 
system. It has been reported to confer higher drug 
concentration in an aqueous milieu by partitioning the 
drugs into the hydrophobic core compartment, in 
particular when the solubility issues limit accessibility 
of the hydrophobic drugs. These characteristics can 
grant an excellent physiological stabilities and 
biocompatibilities in the blood stream to achieve 
long-circulating time [29]. This long-circulating 
ability in turn makes it possible to accumulate the 
encapsulated drugs in the required regions via an 
active and/or a passive mechanism, in particular when 
they are used for targeting of cancer [6, 7, 5].  
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Upon our data, the poly (NIPAAm-MAA-VP) 
nanoparticles showed no chemical interaction with 
the model drug and we witnessed fairly high capacity 
of loading efficiencies (95-99%) for Farnesiferol C 
which is a hydrophobic compound. To investigate the 
effect of temperatures on drug release pattern, the 
release experiments were performed at two different 
temperatures of 37 °C and 40 °C. The effect of 
PNIPAAm hydrogel layers on the nanoparticle 
surface at higher temperature affected drug release 
patterns (at 40°C). Owing to the increase of 
hydrophobicity of the poly (NIPAAm-MAA-VP) 
nanoparticles shell compartments, the sustained drug 
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release patterns were increased. Therefore, it is 
possible to conclude that the formation of PNIPAAm 
hydrogel layer at higher temperatures might be act as 
additional diffusion barrier for the drug release.  
The initial burst release of Farnesiferol C was 
attributed to Farnesiferol C molecules located within 
the corona or at the interface between the micelle core 
and corona [30, 31].  
 
Table 1. H-NMR information of Farnesiferol C 
produced from ferula szowitsiana. 
 
This clearly implies that this thermally responsive 
amphiphilic nanopolymer would be able to be used 
for the encapsulation of poorly soluble hydrophobic 
drugs. Also the Farnesiferol C loaded nanoparticles 
were stable for more than one month at physiological 
conditions. Therefore we can use this system as a 
good carrier to sustained drug release at physiological 
environments. Another main foci on this research is 
investigation of stimuli responsive, especially 
temperature sensitive polymeric nanoparticles an 
efficient drug carrier.  
 
Conclusion 
To achieve a stimuli–response targeting mechanism, 
we aimed to synthesize and characterize the poly 
(NIPAAm-MAA-VP) as a thermosensitive polymeric 
nano-scaled micelle for hydrophobic drugs, in which 
the Farnesiferol C was opted as an anticancer agent. 
Owing to the amphiphilic charactereistics of these 
nanostructures, the poly (NIPAAM-VP-MAA) 
formed self-assembled nanoparticles which displayed 
fairly high potentials to be used as drug carriers. The 
release profile showed faster release rate of 
Farnesiferol C from Farnesiferol C -loaded micelles 
at 40°C, which clearly indicates thermosensitive 
potential of these nanosystems. Upon these findings, 
we propose that these micelle might provide 
opportunities to construct smart drug delivery 
systems. 
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